ReCode Therapeutics Appoints Erica Jefferson as Senior Vice President of Corporate Affairs
ReCode Therapeutics , a clinical-stage genetic medicines company using superior delivery to power the next wave of mRNA and gene correction therapeutics, announced today the appointment of Erica Jefferson as senior vice president of corporate affairs.
- ReCode Therapeutics , a clinical-stage genetic medicines company using superior delivery to power the next wave of mRNA and gene correction therapeutics, announced today the appointment of Erica Jefferson as senior vice president of corporate affairs.
- She will report directly to Shehnaaz Suliman, M.D., MBA, M.Phil., chief executive officer, ReCode Therapeutics.
- Previously, she served as vice president of corporate communications at Dermira, Inc., where she led communications at the corporate, executive, product and employee levels and helped to expand the company’s investor relations activities.
- Prior to Dermira, Ms. Jefferson led external communications in support of two label expansions as senior director of corporate communications at Pharmacyclics, Inc.